Haemonetics (HAE) Profit After Tax (2009 - 2026)

Haemonetics' Profit After Tax history runs 18 years deep, the most recent figure standing at -$20.1 million for Q1 2026.

• On a quarterly basis, Profit After Tax fell 134.75% year-over-year to -$20.1 million in Q1 2026; TTM through Mar 2026 was $97.3 million, a 41.97% decrease from a year earlier, with the FY2026 full-year figure at $97.3 million, down 41.97% from the prior year.
• Profit After Tax retreated to -$20.1 million in Q1 2026 per HAE's latest filing, from $44.7 million in the prior quarter.
• Across five years, Profit After Tax topped out at $58.0 million in Q1 2025 and bottomed at -$20.1 million in Q1 2026.
• The 5-year median for Profit After Tax is $33.9 million (2024), against an average of $30.2 million.
• Across the five-year window, Profit After Tax soared 546.27% in 2022 and sank 134.75% in 2026, its largest moves.
• Year by year, Profit After Tax stood at $37.4 million in 2022, then rose by 5.79% to $39.6 million in 2023, then fell by 5.23% to $37.5 million in 2024, then grew by 19.33% to $44.7 million in 2025, then plunged by 145.03% to -$20.1 million in 2026.
• Per Business Quant, the three latest HAE Profit After Tax figures stand at -$20.1 million (Q1 2026), $44.7 million (Q4 2025), and $38.7 million (Q3 2025).